294. Congenital diaphragmatic hernia Clinical trials / Disease details
Clinical trials : 15 / Drugs : 36 - (DrugBank : 6) / Drug target genes : 5 - Drug target pathways : 14
Showing 1 to 10 of 15 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05213676 (ClinicalTrials.gov) | January 1, 2023 | 27/1/2022 | Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The NoNO Trial - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia(CDH) - The NoNO Trial - a Multi-cente ... | Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The NoNO Trial - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia(CDH) - The NoNO Trial - a Multi-cente ... | Congenital Diaphragmatic Hernia | Drug: Inhaled Nitric Oxide (iNO) use;Other: De-implementation of Inhaled Nitric Oxide (iNO) use | The University of Texas Health Science Center, Houston | NULL | Not yet recruiting | N/A | 1 Month | All | 600 | Phase 4 | United States |
2 | ChiCTR2000037331 | 2020-09-01 | 2020-08-28 | AI-assisted diagnosis and treatment engine based on a fully structured congenital diaphragmatic hernia disease database AI-assisted diagnosis and treatment engine based on a fully structured congenital diaphragmatic hern ... | AI-assisted diagnosis and treatment engine based on a fully structured congenital diaphragmatic hernia disease database AI-assisted diagnosis and treatment engine based on a fully structured congenital diaphragmatic hern ... | Congenital diaphragmatic hernia | intervention group:sildenafil + conventional therapy;control group:conventional therapy; | Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine | NULL | Recruiting | 0 | 5 | Both | intervention group:100;control group:100; | China | |
3 | EUCTR2017-000421-13-IT (EUCTR) | 20/03/2020 | 06/10/2020 | Newborns with Congenital diaphragmatic hernia; iNO versus sildenafil | Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: an international randomized controlled trial - CoDiNOS Trial Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: a ... | Congenital diaphragmatic hernia with pulmonary hypertension MedDRA version: 20.0;Level: SOC;Classification code 10038738;Term: Respiratory, thoracic and mediastinal disorders;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital diaphragmatic herniawith pulmonary hypertension MedDRA version: 20.0;Level: SOC;Classific ... | Trade Name: REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML Product Name: Sildenafil Product Code: [na] INN or Proposed INN: Sildenafil Trade Name: INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI Product Name: INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO Product Code: [na] INN or Proposed INN: OSSIDO DI AZOTO Other descriptive name: Nitric oxide Trade Name: REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACO ... | ERASMUS MEDICAL CENTER | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 330 | Phase 3 | Spain;Belgium;Austria;Norway;Netherlands;Germany;Italy;Sweden | ||
4 | EUCTR2017-000421-13-BE (EUCTR) | 07/02/2019 | 19/02/2019 | Treatment of high blood pressure in the lungs in newborns with a defect in the diaphragm; inhaled Nitric Oxide compared to intravenous Sildenafil. Treatment of high blood pressure in the lungs in newborns with a defect in the diaphragm; inhaled Ni ... | Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: an international randomized controlled trial - CoDiNOS trial Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: a ... | Congenital diaphragmatic hernia with pulmonary hypertension;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital diaphragmatic herniawith pulmonary hypertension;Therapeutic area: Diseases [C] - Congenit ... | Trade Name: revatio 0.8mg/ml solution for injection Trade Name: INOmax 800ppm mol/mol inhalatiegas INN or Proposed INN: NITRIC OXIDE Trade Name: Neophyr 1000ppm mol/mol Trade Name: revatio 0.8mg/ml solution for injection Trade Name: INOmax800ppm mol/mol inhalatiegas INN ... | Erasmus MC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 330 | Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ... | Belgium;Austria;Netherlands | ||
5 | NCT03526588 (ClinicalTrials.gov) | August 1, 2018 | 27/4/2018 | Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diap ... | Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diap ... | Congenital Diaphragmatic Hernia | Biological: Autologous umbilical cord blood | The University of Texas Health Science Center, Houston | Texas Medical Center Regenerative Medicine Consortium | Recruiting | N/A | 7 Days | All | 20 | Phase 1 | United States |
6 | EUCTR2017-000421-13-AT (EUCTR) | 13/07/2018 | 08/05/2018 | Treatment of high blood pressure in the lungs in newborns with a defect in the diaphragm; inhaled Nitric Oxide compared to intravenous Sildenafil. Treatment of high blood pressure in the lungs in newborns with a defect in the diaphragm; inhaled Ni ... | Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: an international randomized controlled trial - CoDiNOS trial Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: a ... | Congenital diaphragmatic hernia with pulmonary hypertension;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital diaphragmatic herniawith pulmonary hypertension;Therapeutic area: Diseases [C] - Congenit ... | Trade Name: revatio 0.8mg/ml solution for injection INN or Proposed INN: Sildenafil Trade Name: INOmax 800ppm mol/mol inhalatiegas INN or Proposed INN: NITRIC OXIDE Trade Name: revatio 0.8mg/ml solution for injection INN or Proposed INN: Sildenafil Trade Name: INOmax ... | Erasmus MC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 330 | Phase 4 | Austria;Netherlands | ||
7 | NCT03787160 (ClinicalTrials.gov) | March 22, 2018 | 10/7/2018 | Microbiome and Volatile Organic Compounds in Patients With CDH | Determining the Effect of Probiotics on Microbiome and Volatile Organic Compounds in Patients After Surgical Repair of Congenital Diaphragmatic Hernia Determining the Effect of Probiotics on Microbiome and Volatile Organic Compounds in Patients After ... | Congenital Diaphragmatic Hernia | Diagnostic Test: initial VOC;Diagnostic Test: initial fecal microbiome;Diagnostic Test: initial pulmonary microbiome;Diagnostic Test: Maximum oxygen uptake;Diagnostic Test: Functional residual capacity;Dietary Supplement: Probiotic treatment;Diagnostic Test: VOC probiotic;Diagnostic Test: Fecal microbiome probiotic;Diagnostic Test: Pulmonary microbiome probiotic Diagnostic Test: initial VOC;Diagnostic Test: initial fecal microbiome;Diagnostic Test: initial pulm ... | Medical University of Graz | University of Rostock | Completed | 6 Years | 16 Years | All | 18 | N/A | Austria |
8 | NCT02951130 (ClinicalTrials.gov) | August 22, 2017 | 14/10/2016 | Milrinone in Congenital Diaphragmatic Hernia | Milrinone in Congenital Diaphragmatic Hernia | Congenital Diaphragmatic Hernia;Persistent Pulmonary Hypertension of the Newborn;Hypoxemic Respiratory Failure;Pulmonary Hypoplasia Congenital Diaphragmatic Hernia;Persistent Pulmonary Hypertension of the Newborn;Hypoxemic Respirato ... | Drug: Milrinone;Drug: Placebo (5% Dextrose) | NICHD Neonatal Research Network | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Recruiting | N/A | 168 Hours | All | 66 | Phase 2 | United States |
9 | EUCTR2017-000421-13-NL (EUCTR) | 27/07/2017 | 07/06/2017 | Treatment of high blood pressure in the lungs in newborns with a defect inthe diaphragm; inhaled Nitric Oxide compared to intravenous Sildenafil. Treatment of high blood pressure in the lungs in newborns with a defect inthe diaphragm; inhaled Nit ... | Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxideversus intravenous Sildenafil:an international randomized controlled trial - CoDiNOS trial Newborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxideversus intravenous Sildenafil:an ... | Congenital diaphragmatic hernia with pulmonary hypertension;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital diaphragmatic herniawith pulmonary hypertension;Therapeutic area: Diseases [C] - Congenit ... | Trade Name: revatio 0.8mg/ml solution for injection Trade Name: INOmax 800ppm mol/mol inhalatiegas | Erasmus MC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 3 | Belgium;Austria;Norway;Netherlands;Sweden | ||
10 | EUCTR2013-002026-22-NL (EUCTR) | 24/10/2013 | 27/06/2013 | Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm. Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonat ... | Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia o ... | GORD,;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] | Trade Name: Losec Product Name: Omeprazol Product Code: NA Trade Name: Losec Product Name: Omeprazol Product Code: NA Trade Name: Losec Product Name: Omeprazol Product Code: NA Trade Name: Losec Product Name: Omeprazol Prod ... | ErasmusMC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands |